[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337069-105":59,"doc-detail-337069-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hedgehog-pathway-is-a-regulator-of-stemness-in-her2-positive-trastuzumab-resistant-breast-cancer","Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer","","HER2 overexpression occurs in 20–30% of breast cancers and links to poor prognosis, while trastuzumab remains standard therapy for HER2-positive disease. Yet resistance develops in about half of patients within a year. The Hedgehog (Hh) pathway regulates stemness in multiple cancers and may drive trastuzumab resistance. This study evaluates Hedgehog signaling’s role in maintaining stemness and promoting resistance in HER2-positive, trastuzumab-resistant cell lines.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hedgehog-pathway-is-a-regulator-of-stemness-in-her2-positive-trastuzumab-resistant-breast-cancer/337069/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hedgehog-pathway-is-a-regulator-of-stemness-in-her2-positive-trastuzumab-resistant-breast-cancer/337069.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How prevalent is HER2 overexpression and why is it clinically important?","Question",{"text":112,"@type":113},"HER2 overexpression occurs in 20–30% of breast tumors and is associated with poor prognosis, indicating a more aggressive disease course.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the study’s main goal regarding the Hedgehog pathway?",{"text":117,"@type":113},"The study investigates how Hedgehog signaling regulates stemness and contributes to trastuzumab resistance in HER2-positive breast cancer cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What was observed after inhibiting or activating Hedgehog signaling?",{"text":121,"@type":113},"Trastuzumab-resistant cells showed increased Hedgehog activity; inhibiting Hedgehog with GANT61 downregulated stemness markers, while activating with SAG21K upregulated them.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337069,1790537256,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Article  \nHedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer  \nIdris Er 1 and Asiye Busra Boz Er 2, *  \nCitation: Er, I.; Boz Er, A.B. Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer. Int. J. Mol. Sci. 2024, 25, 12102. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms252212102  \nAcademic Editor: Farzad Pakdel  \nReceived: 30 September 2024  \nRevised: 31 October 2024  \nAccepted: 5 November 2024  \nPublished: 11 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Medical Biology, Faculty of Medicine, Karadeniz Technical University, Trabzon 61080, Turkey; [idriser@ktu.edu.tr](idriser@ktu.edu.tr)  \n2 Department of Medical Biology, Faculty of Medicine, Recep Tayyip Erdogan University, Rize 53100, Turkey  \n* Correspondence: [asiyebusra.bozer@erdogan.edu.tr](asiyebusra.bozer@erdogan.edu.tr)  \nAbstract: HER2 overexpression occurs in 20–30% of breast cancers and is associated with poor prognosis. Trastuzumab is a standard treatment for HER2-positive breast cancer; however, resistance develops in approximately 50% of patients within a year. The Hedgehog (Hh) signalling pathway, known for its role in maintaining stemness in various cancers, may contribute to trastuzumab resistance in HER2-positive breast cancer. This study aimed to investigate the role of Hedgehog signalling in maintaining stemness and contributing to trastuzumab resistance in HER2-positive breast cancer cell lines. Trastuzumab-resistant HER2-positive breast cancer cell lines, SKBR3 and HCC1954, were developed through continuous trastuzumab exposure. Cells were treated with GANT61 (Hh inhibitor, IC 50:10 µM) or SAG21K (Hh activator, IC 50:100 nM) for 24 h to evaluate the Hedgehog signalling response. Stemness marker expression (Nanog, Sox2, Bmi1, Oct4) was measured using qRT-PCR. The combination index (CI) of GANT61 with trastuzumab was calculated using CompuSyn software (version 1.0) to identify synergistic doses (CI \u003C 1) . The synergistic concentrations’impact on stemness markers was assessed. Data were analysed using two-way ANOVA and Tukey’s post hoc test (p \u003C 0.05) . Trastuzumab-resistant cells exhibited increased Hedgehog signalling activity. Treatment with GANT61 significantly downregulated stemness marker expression, while SAG21K treatment led to their upregulation in both SKBR3-R and HCC1954-R cells. The combination of GANT61 and trastuzumab demonstrated a synergistic effect, markedly reducing the expression of stemness markers. These findings indicate that Hedgehog signalling plays a pivotal role in maintaining stemness in trastuzumab-resistant cells, and that the inhibition of this pathway may prevent tumour progression. Hedgehog signalling is crucial in regulating stemness in trastuzumabresistant HER2-positive breast cancer. Targeting this pathway could overcome resistance and enhance trastuzumab efficacy. Further studies should explore the clinical potential of Hedgehog inhibitors in combination therapies.  \nKeywords: breast cancer; hedgehog; stemness  \n1. Introduction  \nHER2 (Human Epidermal Growth Factor Receptor 2) is overexpressed in 20–30% of breast tumours and is associated with poor prognosis [1] . Trastuzumab is an FDA-approved treatment for HER2-positive breast cancer that reduces HER2 overactivity through various mechanisms, including preventing HER2 dimerization, downregulating the HER2 receptor via endocytic destruction, and inhibiting HER2 cleavage by metalloproteases [2] . Nevertheless, resistance is a major issue, with around 50% of HER2-positive breast cancer patients developing res","cbCaiqQVzaIMHJrV","https://ap.wps.com/l/cbCaiqQVzaIMHJrV","pdf",1633974,11,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"How prevalent is HER2 overexpression and why is it clinically important?\",\"answer\":\"HER2 overexpression occurs in 20–30% of breast tumors and is associated with poor prognosis, indicating a more aggressive disease course.\"},{\"question\":\"What is the study’s main goal regarding the Hedgehog pathway?\",\"answer\":\"The study investigates how Hedgehog signaling regulates stemness and contributes to trastuzumab resistance in HER2-positive breast cancer cell lines.\"},{\"question\":\"What was observed after inhibiting or activating Hedgehog signaling?\",\"answer\":\"Trastuzumab-resistant cells showed increased Hedgehog activity; inhibiting Hedgehog with GANT61 downregulated stemness markers, while activating with SAG21K upregulated them.\"}]","Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer | PDF",1790017618,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bfeb2fee9f875e7df12afda4f563a87.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d510254fbb435828a035787fb64f987.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e688745133924e9e86138c6a0107bab0.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75acf74d58528924bb1b33d15c1c75ba.webp",980,1385]